| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bda6098cbd052c6e0bd7d1cd026c483c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c39a0eaddbb0f93be122834b3cd9acd8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d9072cb25d6ae674a3943f14e5771e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cab8e51148703e3444c8e69c6e7049a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e6d5ae7bdf5b19fbfa4679f69c9552e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-602 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 |
| filingDate |
2006-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bac8e887790e4bbf7e2f07d16e9723ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27a68973e00070433e01c1af05ceff51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abde1a3d8c4769ae60f4cb0abe4c138b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce326cb253e33ba50caeb6ba57fa8cd6 |
| publicationDate |
2006-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006137222-A1 |
| titleOfInvention |
Method for control of drug elution rate and composition for coating of drug-eluting stent |
| abstract |
Disclosed are a method for controlling the elution of a drug from a stent and a drug-eluting stent capable of reducing the restenosis rate after therapy. A coating composition for a drug-eluting stent comprising an endothelin receptor antagonist and a copolymer of 2-methacryloyloxyethyl phosphorylcholine and n-butyl methacrylate. The elution of the endothelin receptor antagonist from the coating composition can be controlled by varying the ratio of 2-methacryloyloxyethyl phosphorylcholine to n-butyl methacrylate in the copolymer. |
| priorityDate |
2005-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |